Literature DB >> 20843421

Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.

G Chamie1, A Luetkemeyer, M Walusimbi-Nanteza, A Okwera, C C Whalen, R D Mugerwa, D V Havlir, E D Charlebois.   

Abstract

BACKGROUND: The human immunodeficiency virus (HIV) alters the presentation of pulmonary tuberculosis (PTB), but it remains unclear whether alterations occur at a CD4 cell threshold or throughout HIV infection.
OBJECTIVE: To better understand the relationship between CD4 count and clinical and radiographic presentation of PTB. SETTING AND
DESIGN: Initial presentations of culture-confirmed PTB patients evaluated at a Ugandan national TB referral center and an affiliated research unit were compared by HIV status and across 11 CD4 cell count strata: 0-50 to >500 cells/μl.
RESULTS: A total of 873 HIV-infected PTB cases were identified. Among HIV-infected PTB cases with CD4 < 50, 21% had a normal chest X-ray (CXR) vs. 2% with CD4 > 500, with a continuous trend across CD4 strata (test for trend, P < 0.001). All radiographic manifestations of PTB displayed significant trends across CD4 strata. HIV-infected vs. non-HIV-infected patients had no significant difference in CXR findings of miliary patterns or pleural effusion at CD4 > 100, normal CXR or fibrosis at CD4 > 150, adenopathy at CD4 > 250, and cavitation or upper lung disease at CD4 > 300. Twenty-three per cent of co-infected cases with CD4 < 50 and 1% with CD4 > 500 had negative acid-fast bacilli (AFB) smears, with a significant trend between (P < 0.001).
CONCLUSION: Variations in CXR appearance and AFB smear correlate with CD4 decline in significant, continuous trends.

Entities:  

Mesh:

Year:  2010        PMID: 20843421      PMCID: PMC3033769     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  26 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998.

Authors:  N A Ansari; A H Kombe; T A Kenyon; N M Hone; J W Tappero; S T Nyirenda; N J Binkin; S B Lucas
Journal:  Int J Tuberc Lung Dis       Date:  2002-01       Impact factor: 2.373

3.  Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia.

Authors:  M E Kimerling; J Schuchter; E Chanthol; T Kunthy; F Stuer; P Glaziou; O Ee
Journal:  Int J Tuberc Lung Dis       Date:  2002-11       Impact factor: 2.373

4.  Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya.

Authors:  F S Rana; M P Hawken; C Mwachari; S M Bhatt; F Abdullah; L W Ng'ang'a; C Power; W A Githui; J D Porter; S B Lucas
Journal:  J Acquir Immune Defic Syndr       Date:  2000-05-01       Impact factor: 3.731

5.  A Wilcoxon-type test for trend.

Authors:  J Cuzick
Journal:  Stat Med       Date:  1985 Jan-Mar       Impact factor: 2.373

Review 6.  Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.

Authors:  Y D Mukadi; D Maher; A Harries
Journal:  AIDS       Date:  2001-01-26       Impact factor: 4.177

7.  The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS.

Authors:  A E Pitchenik; H A Rubinson
Journal:  Am Rev Respir Dis       Date:  1985-03

Review 8.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

9.  CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection.

Authors:  M D Keiper; M Beumont; A Elshami; C P Langlotz; W T Miller
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

10.  Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance).

Authors:  S D Greenberg; D Frager; B Suster; S Walker; C Stavropoulos; A Rothpearl
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

View more
  46 in total

Review 1.  Economic challenges associated with tuberculosis diagnostic development.

Authors:  Colleen F Hanrahan; Maunank Shah
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-04-28       Impact factor: 2.217

Review 2.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

3.  Disseminated tuberculosis in HIV-infected patients from the Regional HIV/AIDS Center Constanţa, Romania.

Authors:  Sorin Rugină; Irina-Magdalena Dumitru; Ghiulendan Resul; Roxana Carmen Cernat; Andra Elena Petcu
Journal:  Germs       Date:  2014-03-03

4.  Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.

Authors:  Lydia Nakiyingi; Vineshree Mischka Moodley; Yukari C Manabe; Mark P Nicol; Molly Holshouser; Derek T Armstrong; Widaad Zemanay; Welile Sikhondze; Olive Mbabazi; Bareng A S Nonyane; Maunank Shah; Moses L Joloba; David Alland; Jerrold J Ellner; Susan E Dorman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

5.  Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.

Authors:  Emmanuel Ssemmondo; Florence Mwangwa; Joel L Kironde; Dalsone Kwarisiima; Tamara D Clark; Carina Marquez; Edwin D Charlebois; Maya L Petersen; Moses R Kamya; Diane V Havlir; Gabriel Chamie
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

6.  Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.

Authors:  Anne F Luetkemeyer; Michelle A Kendall; Xingye Wu; Maria Cristina Lourenço; Ute Jentsch; Susan Swindells; Sarojini S Qasba; Jorge Sanchez; Diane V Havlir; Beatriz Grinsztejn; Ian M Sanne; Cynthia Firnhaber
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

7.  Tuberculosis Transmission or Mortality Among Persons Living with HIV, USA, 2011-2016.

Authors:  K M Schmit; N Shah; S Kammerer; S Bamrah Morris; S M Marks
Journal:  J Racial Ethn Health Disparities       Date:  2020-02-14

8.  The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.

Authors:  Chuan-Chin Huang; Eric Tchetgen Tchetgen; Mercedes C Becerra; Ted Cohen; Katherine C Hughes; Zibiao Zhang; Roger Calderon; Rosa Yataco; Carmen Contreras; Jerome Galea; Leonid Lecca; Megan Murray
Journal:  Clin Infect Dis       Date:  2013-12-23       Impact factor: 9.079

Review 9.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

Review 10.  Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.

Authors:  Kerry L Dierberg; Richard E Chaisson
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.